
Episode 13: You get blinatumomab! You get blinatumomab!
WolverHeme Happy Hour
00:00
The Effects of Blint on Survival in MRD Positive Patients
Blint works well at taking patients from MRD positive to MRD negative states, and it's the standard of care in that setting. But what we don't know is does it actually improve survival when we give it to MRD positive patients? And if we added it to MRd negative patients, would it also improve outcomes? Yes, very excellent summary. Patrick, I know we were approached, what, six, seven years ago, right around the time that you started at U of M to participate in the study. We're kind of kicking ourselves in the head because of that. So why don't you give us a little bit of background of what E-COG is and
Transcript
Play full episode